Free Trial

Cogent Biosciences (COGT) Short Interest Ratio & Short Volume

$10.98
+0.08 (+0.73%)
(As of 09/20/2024 ET)

Cogent Biosciences Short Interest Data

Cogent Biosciences (COGT) has a short interest of 10.25 million shares. This marks a 0.20% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.1, indicating that it would take 10.1 days of the average trading volume of 1.50 million shares to cover all short positions.

Current Short Interest
10,250,000 shares
Previous Short Interest
10,230,000 shares
Change Vs. Previous Month
+0.20%
Dollar Volume Sold Short
$110.09 million
Short Interest Ratio
10.1 Days to Cover
Last Record Date
August 31, 2024
Outstanding Shares
109,450,000 shares
Percentage of Shares Shorted
9.37%
Today's Trading Volume
2,585,628 shares
Average Trading Volume
1,495,240 shares
Today's Volume Vs. Average
173%
Short Selling Cogent Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

COGT Short Interest Over Time

COGT Days to Cover Over Time

COGT Percentage of Float Shorted Over Time

Cogent Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202410,250,000 shares $110.09 million +0.2%N/A10.1 $10.74
8/15/202410,230,000 shares $89.21 million +1.2%N/A9.3 $8.72
7/31/202410,110,000 shares $95.34 million -2.7%N/A9.3 $9.43
7/15/202410,390,000 shares $96.11 million +7.3%N/A8.5 $9.25
6/30/20249,680,000 shares $81.60 million -32.4%N/A7.3 $8.43
6/15/202414,320,000 shares $120.65 million -0.6%N/A10.4 $8.43
5/31/202414,400,000 shares $115.34 million +7.0%N/A10.3 $8.01
5/15/202413,460,000 shares $103.91 million +11.8%N/A8.7 $7.72
4/30/202412,040,000 shares $78.26 million -3.5%N/A5.8 $6.50
4/15/202412,470,000 shares $81.06 million +15.0%N/A5.9 $6.50
3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72
3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05
2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00
2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88
1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43
1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06
12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88
12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88
11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67
11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68
10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16
10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52
9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75
9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76
8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21
8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29
7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99
7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53
6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84
6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61
5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74
5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90
4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76
4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27
3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79
3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16
2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23
2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72
1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06
1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03
Forget Trump and Kamala (Ad)

Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.

Download my Dividend Calendar here
12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56
12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96
11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58
11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71
10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65
10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61
9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92
9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43
8/31/20223,220,000 shares $53.10 million -30.6%N/A1 $16.49
8/15/20224,640,000 shares $67.79 million -10.1%N/A1.5 $14.61
7/31/20225,160,000 shares $57.22 million -9.2%N/A1.8 $11.09
7/15/20225,680,000 shares $60.83 million +19.3%N/A2 $10.71
6/30/20224,760,000 shares $42.94 million +9.7%N/A1.7 $9.02
6/15/20224,340,000 shares $36.20 million +99.1%11.9%1.6 $8.34
5/31/20222,180,000 shares $10.05 million +6.9%6.0%6.4 $4.61
5/15/20222,040,000 shares $8.28 million +13.3%5.6%6.4 $4.06
4/30/20221,800,000 shares $11.56 million +20.8%4.8%6.4 $6.42
4/15/20221,490,000 shares $13.02 million -13.9%4.0%6 $8.74
3/31/20221,730,000 shares $12.96 million -7.0%4.6%7.9 $7.49
3/15/20221,860,000 shares $10.30 million +12.1%5.1%11.4 $5.54
2/28/20221,660,000 shares $9.84 million +4.4%5.2%10.2 $5.93
2/15/20221,590,000 shares $11.00 million +9.7%5.0%9.1 $6.92
1/31/20221,450,000 shares $10.96 million +4.3%4.2%5.1 $7.56
1/15/20221,390,000 shares $11.30 million +2.2%4.1%4.7 $8.13
12/31/20211,360,000 shares $11.67 million -2.2%4.0%4.6 $8.58
12/15/20211,390,000 shares $11.50 million +28.7%4.1%4.8 $8.27
11/30/20211,080,000 shares $8.55 million -23.4%3.2%3.7 $7.92
11/15/20211,410,000 shares $14.55 million -20.8%4.1%5 $10.32
10/29/20211,780,000 shares $15.09 million -6.8%5.2%9.3 $8.48
10/15/20211,910,000 shares $17.65 million -9.5%5.6%12.2 $9.24
9/30/20212,110,000 shares $17.75 million -4.1%6.2%12.5 $8.41
9/15/20212,200,000 shares $17.95 million +2.8%6.4%8.7 $8.16
8/31/20212,140,000 shares $17.72 million +0.5%6.2%7 $8.28
8/13/20212,130,000 shares $16.83 million +4.4%6.2%7.2 $7.90
7/30/20212,040,000 shares $12.24 million -1.0%5.8%7.1 $6.00
7/15/20212,060,000 shares $13.95 million +4.6%5.9%6.6 $6.77
6/30/20211,970,000 shares $15.98 million +34.0%5.6%5.9 $8.11
6/15/20211,470,000 shares $13.32 million -0.7%4.2%5.5 $9.06
5/28/20211,480,000 shares $12.82 million -4.5%4.2%5.5 $8.66
5/14/20211,550,000 shares $12.32 million -34.9%4.4%4.7 $7.95
4/30/20212,380,000 shares $20.44 million +0.4%6.9%6.5 $8.59
4/15/20212,370,000 shares $20.93 million -16.0%7.1%5.8 $8.83
3/31/20212,820,000 shares $23.52 million +8.9%8.5%6.9 $8.34
3/15/20212,590,000 shares $21.19 million +19.4%7.4%5.7 $8.18
2/26/20212,170,000 shares $17.79 million +42.8%3.8%4.6 $8.20
2/12/20211,520,000 shares $15.05 million +54.0%2.6%3.1 $9.90
1/29/2021987,300 shares $8.97 million +31.6%3.9%2.2 $9.09
1/15/2021750,000 shares $8.93 million No Change1.5%1.8 $11.90

COGT Short Interest - Frequently Asked Questions

What is Cogent Biosciences' current short interest?

Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 10,250,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest.

What is a good short interest ratio for Cogent Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 10.0. Learn More on Cogent Biosciences's short interest ratio.

Which institutional investors are shorting Cogent Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cogent Biosciences: Millennium Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Cogent Biosciences' short interest increasing or decreasing?

Cogent Biosciences saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,250,000 shares, an increase of 0.2% from the previous total of 10,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cogent Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cogent Biosciences: Enlivex Therapeutics Ltd. (0.45%), Aytu BioPharma, Inc. (5.62%), TG Therapeutics, Inc. (21.39%), Biohaven Ltd. (11.56%), MoonLake Immunotherapeutics (15.13%), Rhythm Pharmaceuticals, Inc. (15.77%), Xenon Pharmaceuticals Inc. (4.71%), Dyne Therapeutics, Inc. (7.86%), Merus (11.30%), Iovance Biotherapeutics, Inc. (23.34%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.

What does it mean to sell short Cogent Biosciences stock?

Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cogent Biosciences?

A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further.

How often is Cogent Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is August, 31 2024.




This page (NASDAQ:COGT) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners